Table 1.
Investigations | Results | Normal range |
Hb | 73 (L) | 120–160 g/L |
Hct | 23.0 (L) | 36.0%–46.0% |
MCV | 91.3 | 80.0–100.0 fL |
MCH | 29.0 | 26.0–34.0 pg |
MCHC | 317 | 314–358 g/L |
RDW | 20.6 (H) | 11.5%–13.4% |
White cell count | 12.82 (H) | 3.50–11.00×109/L |
Neutrophils percentage | 33.3 (L) | 48.0%–82.0% |
Lymphocyte percentage | 63.4 (H) | 19.0%–48.0% |
Absolute neutrophil count | 4.27 | 1.70–9.00×109/L |
Absolute lymphocyte count | 8.13 (H) | 1.20–3.50×109/L |
Platelet | 233 | 150–440×109/L |
Total bilirubin | 3.1 (H) | 0.1–1.5 mg/dL |
Direct bilirubin | 0.4 | 0.0–1.5 mg/dL |
AST | 49 (H) | 0–40 U/L |
ALT | 18 | 0–45 U/L |
ALP | 65 | 30–120 U/L |
Serum amylase | 73 | 40–130 U/L |
Serum lipase | 30 | 8–78 U/L |
Urine bilirubin | Moderate (H) | Negative |
Urine urobilinogen | ≥8.0 (H) | 0.1–1.0 EU/dL |
ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; H, high; Hb, haemoglobin; Hct, hematocrit; L, low; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration; MCV, mean corpuscular volume; RDW, red cell distribution width.